Reuters

Genzyme MS drug effective but monitoring required

BOSTON, Oct 14 (Reuters) - Genzyme Corp said on Sunday that three-year data from a mid-stage trial of its experimental multiple sclerosis drug showed it to be very effective, but patients must be ...
Reuters

Genzyme MS drug data remains strong after 5 years

BOSTON (Reuters) - Genzyme Corp presented new data from a trial of its experimental multiple sclerosis drug alemtuzumab on Thursday that continued to show strong efficacy with no new or worsening side ...
The Business Journals

Genzyme’s MS drug approval in doubt after scathing FDA report

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Less than two months after Genzyme’s newest drug to treat ...
WBJournal

Genzyme Corp.

How do you whittle 35 years of headlining business news down to a couple thousand words and a few pages? You don't. But here, we take our best shot to highlight the companies, individuals, and moments ...